Cancer Clinical Trials Office Blog

News & Updates from the CCTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • Cancer Clinical Trials Office
  • Stanford Cancer Institute

New Division Chiefs

December 11, 2020 - Katy McCormack

Important Message from Robert A. Harrington, MD

Arthur L. Bloomfield Professor

Chair, Department of Medicine

I’m very pleased to announce the appointment of two Division Chiefs. David Miklos has agreed to accept the role of Division Chief, Bone and Marrow Transplantation; and Heather Wakelee has agreed to accept the position of Division Chief, Oncology. Heather also assumes the role of Deputy Director, Stanford Cancer Institute. I am grateful to both for taking on these positions at a challenging time for our department and Stanford Medicine. Please join me in welcoming them to these roles.

David Miklos, MD, PhD received both his MD degree and his PhD in Genetics from Yale.  He completed internship and residency at the Brigham and Women’s Hospital and his fellowship in Hem-Onc at Dana Farber.  Dr. Miklos joined the Stanford faculty in 2004. His laboratory research discovered allogeneic B lymphocytes as a pathogenic mechanism in chronic graft versus host disease (cGVHD), pioneered high-throughput DNA lymphoid measurement of residual disease (MRD), and established the clinical utility of CAR-T therapies in Lymphoma. He has led 7 Investigator initiated trials and 5 industry sponsored studies with Site PI responsibilities in multiple others. His laboratory research supported anti-B cell therapy for the management of cGVHD and he developed and led the pivotal study of Bruton Tyrosine kinase (BTK) inhibitor Ibrutinib for patients with cGVHD resulting in the only FDA approved cGVHD therapy. He currently leads the randomized controlled trial testing Ibrutinib-v-placebo in patients with new onset cGVHD. He served as the Medical Director for Stanford Cellular Therapeutics and Transplantation Laboratory from 2011 to 2016, and since 2016 has been Clinical Director of Cancer Cell Therapy at Stanford.  He has served in the Associate Chief role for BMT since April 2020.  David will be only the third chief in the more than 30 year history of the program.  I know under Dr. Miklos’ leadership the division’s tradition of innovation and singular devotion to improving patient outcomes will continue.  

Heather Wakelee, MD received her MD from Johns Hopkins and completed her Internal Medicine residency here at Stanford, where she also served as Chief Resident; she completed her Fellowship in Oncology here as well.   Dr. Wakelee joined the faculty in 2003.  She was promoted to Professor in 2017, and has served as interim division chief in Oncology since April 2020.  Heather specializes in the treatment of lung cancer, thymoma and mesothelioma. She is the physician lead for the thoracic malignancies clinical research group and is the principal investigator on numerous clinical trials.  Dr. Wakelee is the faculty director of the Stanford Clinical Trials office and is the lead investigator for ECOG-ACRIN clinical trials group at Stanford.  She is active in many national and international organizations related to lung cancer including executive leadership roles in the International Association for the Study of Lung Cancer (IASLC).  With her appointment as Division Chief, Heather has also been appointed Deputy Director of the Stanford Cancer Institute and will report to Director, Dr. Steve Artandi in that role.  I look forward to Dr. Wakelee’s leadership and am inspired by her vision for Oncology. I also want to thank Dr. Rob Negrin for his service, commitment, and excellent leadership in BMT over the last 20 years.  I know that we will have some time to celebrate Rob after his sabbatical (and hopefully after the pandemic).  Please join me in thanking Dr. Negrin and welcoming Dr. Miklos and Dr. Wakelee to their roles.

Thank you, CCTO Team!

December 10, 2020 - Katy McCormack

Dear CCTO Team!

I am reaching out to all of you to share a greeting for the end of 2020, pre-winter “closure” and in a holiday season.

First, I would like to recognize all of you for your contributions this year during this very tricky time. Our patients have struggled and we have all struggled, but we have supported our patients and each other. We will be stronger because of this experience!

Second, I would like to reflect on the coming year of endless possibilities! I can think of many and I am sure you can, too. Vaccine is a big one that comes to mind… being able to be together… traveling… and many more…

Third, I would like to recognize those of who are continuing to work at some level over the winter closure to continue care for our research subjects and maintain research continuity. I am extremely grateful for your work.

And last, but certainly not least, I wish all of you a safe and restful winter closure period, and a happy holidays to those of you who celebrate a holiday during this time. I look forward to “seeing” all of you in 2021!

Best,

Elizabeth Anderson

New Contact for Blog Submissions

November 25, 2020 - Dian Le

Hello CCTO,

Starting in December 2020, Please send all blog submissions to Katy McCormack at katymcc@stanford.edu. Katy will be managing CCTO’s blog during my maternity leave.

Thank you and have a safe Thanksgiving!

Dian Le

Congratulations to Christina Baggott!

October 8, 2020 - Dian Le

Christina Baggott, Clinical Research Nurse Practitioner for the Pediatrics team, recently received the Nightingale Excellence Award from Lucile Packard Children’s Hospital.

The Nightingale Excellence Awards recognizes and honors the extraordinary accomplishments, achievements, and endeavors of our bedside nurses, nurse leaders and colleagues who go above and beyond the call of duty. Thank you for all that you do, Christina!

CCTO HR Office Hours

July 22, 2020 - Dian Le

CCTO, do you have questions regarding timecard entry, benefits, vacation time, disability and leaves?  If so, the CCTO HR Office is holding ZOOM Open Office Hours, daily, between 2pm to 3pm.  No Appointment is necessary.  Simply click on the link below and wait for us to let you into the virtual office for a confidential discussion.  There may be a short wait if there are multiple callers are ahead of you, but no worries, we will get to your call as soon as we can!  Looking forward in chatting with you!

Join Your HR Team During our ZOOM Virtual Hour Mon-Fri from 2pm-3pm: https://stanford.zoom.us/j/895250203

Password: 800802

  • 1
  • 2
  • 3
  • Next Page »

Blog Submissions

If you have an announcement for the blog, please contact Katy McCormack.

Reminder: Please have your blog post submitted to us by end of day Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • OnCore
  • Quality Corner
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube